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Decrease in interstitial pH of the tumor stroma and over-expression of low density lipoprotein (LDL) receptors by several types of neoplastic
cells have been suggested to be important determinants of selective retention of photosensitizers by proliferative tissues. The interactions of
chlorin e6 (Ce6), a photosensitizer bearing three carboxylic groups, with plasma proteins and DOPC unilamellar vesicles are investigated by
fluorescence spectroscopy. The binding constant to liposomes, with reference to the DOPC concentration, is 6×103 M−1 at pH 7.4. Binding of
Ce6 to LDL involves about ten high affinity sites close to the apoprotein and some solubilization in the lipid compartment. The overall association
constant is 5.7×107 M−1 at pH 7.4. Human serum albumin (HSA) is the major carrier (association constant 1.8×108 M−1 at pH 7.4). Whereas the
affinity of Ce6 for LDL and liposomes increases at lower pH, it decreases for albumin. Between pH 7.4 and 6.5, the relative affinities of Ce6 for
LDL versus HSA, and for membranes versus HSA, are multiplied by 4.6 and 3.5, respectively. These effects are likely driven by the ionization
equilibria of the photosensitizer carboxylic chains. Then, the cellular uptake of chlorin e6 may be facilitated by its pH-mediated redistribution
within the tumor stroma.
© 2006 Elsevier B.V. All rights reserved.Keywords: Photosensitizer; pH; Albumin; Lipoprotein; Model membranes1. Introduction
The therapeutic use of photosensitizing drugs is based on
light-induced generation of reactive species that damage
surrounding biological structures [1]. The selective accumula-
tion of photosensitizers in proliferating tissues and the
possibility to define the limits of the irradiated zone are two
main factors insuring the specificity of photodynamic action [2].
The space diffusion of the reactive species, namely oxyradicals
and singlet oxygen, is limited by their extremely short life time
[3]. Thus the extent of the photoinduced damage is restricted to
the structures labeled by the photosensitizer. Consequently, the
uptake and/or retention of photosensitizers by targeted cells or
tissues are crucial determinants of their efficiency. Several
explanations have been proposed to clarify the selective uptake
of porphyrin-type photosensitizers by neoplastic tissues. Firstly,⁎ Corresponding author. Fax: + 33 1 69 87 43 60.
E-mail address: dbrault@ccr.jussieu.fr (D. Brault).
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doi:10.1016/j.bbamem.2006.10.009extracellular accumulation of lactic acid results in the
acidification of tumor interstitial matrix [4,5]. Consistent data
obtained on cultured cells [6,7], animals [8] and membrane
models [9] present strong evidence for a major role of the pH
gradient thus created in the selective tumoral uptake of
photosensitizers bearing carboxylic chains.
Another important determinant of the cellular incorporation
of photosensitizers is their binding to low density lipoproteins
(LDL). This association influences both the overall cellular
uptake and the internalization pathway of the drug. The role of
lipoproteins as blood carriers of photosensitizers has been
proposed by several authors [10–12]. LDL are considered as a
targeting and delivery system of lipophilic or amphiphilic
photosensitizers [13]. Moreover, increased cholesterol require-
ments of proliferating tissues result in the over-expression of
LDL receptors on the cell surface [14,15]. Thus, the cellular
incorporation of lipoprotein bound photosensitizers via LDL-
specific endocytosis has been suggested to be one of the main
mechanisms of their preferential accumulation by tumors. Low-
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with diameters of between 210 and 250 Å. The LDL lipid core
containing cholesteryl esters and triglycerides is surrounded by
a monolayer of cholesterol and phospholipids. The large
apoprotein B100 (500 kDa), associated to the phospholipid
envelope, contributes to the overall structure of the particle and
ensures its recognition by cellular receptors [16]. The number of
photosensitizers bound to LDL and their localization within
these particles are important determinants of this transportation
mode.
In addition, the bioavailability of photosensitizers is
governed by the competitive binding to albumin, the major
protein in plasma [17]. The distribution of certain photosensi-
tizers with various degrees of lipophilicity and numbers of
charges among plasma proteins has been studied by means of
ultracentrifugation [18–21]. A general finding was that the
fraction of the dyes bound to LDL increased, and the fraction
bound to HSA decreased with decreasing polarity of the dyes.
However, the relative binding to these proteins was also
dependent on the position of charges around the macrocycle
[18]. It must be noted that the permeability of neovessels may
allow leakage of albumin-bound photosensitizers into the tumor
stroma, which would also lead to some selective retention [22].
In this study, we consider chlorin e6 (Ce6) that bears three
carboxylic groups (see Fig. 1). This molecule was chosen as it
enabled to the verification of the effect of the number of
carboxylic groups when compared to dicarboxylic porphyrins.
It is also relevant to therapy as a second-generation photo-
sensitizer [23]. Quantitative data on the interactions of Ce6 with
various potential serum carriers, as well as with cell-mimicking
membrane systems, are derived in this paper. The effect of pH is
particularly emphasized.
2. Material and Methods
2.1. Chemicals
Chlorin e6 (Fig. 1) was purchased from Porphyrin Products, Logan (UT,
USA). A stock solution (1 mM) was prepared in 20 mM Na2H PO4. The
experimental Ce6 solutions were diluted in phosphate buffer saline, PBS
(20 mM KH2PO4/Na2HPO4, 150 mM NaCl, pH indicated for each experiment)
and handled in the dark.
Human serum albumin (HSA) was purchased from Sigma (St. Louis, MO,
USA). Experimental solutions were prepared in PBS at the desired pH and were
used immediately.Fig. 1. Structure of chlorin e6.Human low-density lipoproteins (LDL) were purchased from Calbiochem
(San Diego, CA, USA). They were conditioned at a concentration of 9.52 mg/ml
(protein content) in 150 mM NaCl pH 7.4 aqueous solution with 0.01% EDTA.
Dioleyol-sn-phosphatidylcholine (DOPC) was purchased from Avanti Polar
Lipids (Alabaster, AL, USA). Chloroform (Merck, Darmstadt, Germany) was of
spectroscopic grade quality. Triton X-100 was purchased from Sigma (St. Louis,
MO, USA).
2.2. Liposome preparation
DOPC was dissolved in chloroform and the solution was taken to dryness.
The lipid film obtained was rehydrated in PBS and vortexed for several minutes.
The liposome suspension was extruded 10 times through a stack of two
polycarbonate membrane filters (Poretics, Livermore, CA, USA) with a pore
size of 50 nm using an extruder device (Lipex, Biomembranes, Vancouver,
Canada).
2.3. Fluorescence measurements
Fluorescence measurements were performed with an Aminco Bowman
Series 2 spectrofluorimeter. The samples were contained in a 1 cm quartz cell
and were stirred during the acquisition.
2.3.1. Partition experiments: Incorporation of Ce6 in DOPC vesicles
For experiments at equilibrium, the DOPC liposome solutions were prepared
at different concentrations. 10 μL of 10 μM Ce6 solution were added to 2 ml of
vesicle preparation and the fluorescence spectra were recorded. In order to
correct the spectra for small differences in Ce6 concentration arising from
experimental inaccuracy, 20 μL of Triton-X100 were added after measurement
leading to disruption of vesicles and solubilization of all Ce6 in the Triton
micelles. The spectra were normalized accordingly.
The global binding constant, KB, was derived from changes in the
fluorescence signal at a wavelength corresponding to the maximum of
fluorescence emission of Ce6 incorporated into the membrane. We used the
previously derived relationship [24]:
F ¼ F0 þ ðFl F0Þ  KB  ½DOPC1þ KB  ½DOPC ð1Þ
where F0, F∞ and F are the fluorescence intensities corresponding to zero, total
and intermediate incorporation of chlorin into vesicles, respectively. DOPC being
in large excess, the saturation of the bilayer is far to be reached and it can be
assumed that Ce6 binding does not affect the properties of the model membrane.
Then, regardless of the number of Ce6 molecules incorporated into a vesicle,
[DOPC] was assumed to be equivalent to the total DOPC concentration added.
2.3.2. Binding to HSA and LDL
Contrary to former partition experiments, the interactions of Ce6 with HSA
and LDL involved a limited number of sites. Moreover, due to the high affinity
of chlorin to HSA and LDL, the concentration of Ce6 and that of the
macromolecules were of the same order of magnitude in our experimental
conditions. Consequently, the concentration of free sites on HSA or LDL was
calculated by subtracting the amount of bound chlorin to the total number of
binding sites per molecule. For this purpose, the concentrations of free and
bound Ce6 were calculated by a spectral decomposition program running with
the MatLab® (MathWorks, Natick, MA) software according to the equation:
ðSPÞ ¼ Comp1
Comp2
 
 ðfPBS; fBÞ ð2Þ
where SP is the experimental spectrum, Comp1 and Comp2 are the spectra of
Ce6 in PBS and bound to the macromolecule, respectively. Comp2 was obtained
using an excess of the macromolecule to insure total binding. The relative
concentrations of free and bound chlorin are given by the factors fPBS and fB.
The equilibrium of Ce6 binding to the plasma proteins can be written as:
½ChlF þ ½PF
KB
± ½ChlB
Fig. 2. Fluorescence emission spectra of Ce6 (5×10−8 M) in phosphate buffer
(pH=7.4) and in presence of LDL (4×10−7 M), HSA (5×10−6 M) and DOPC
(1.9×10−3 M), λexc=410 nm. The shoulder on the blue side of the spectrum in
presence of LDL corresponds to the unbound fraction of Ce6.
Fig. 3. Fluorescence emission spectra of chlorin e6 (5×10−8 M) in PBS buffered
at pH 6.5, 7.4 and 8.0, λexc: 400 nm.
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The overall binding constant is defined as:
KB ¼ ½ChlB½ChlF  ½PF
ð3Þ
Assuming that nP is the number of binding sites per protein, nP x[P]F is the
averaged concentration of free protein sites. The total protein concentration
being [P]tot, it follows:
½PF ¼ ½Ptot 
½ChlB
nP
 
ð4Þ
Combining Eqs. (3) and (4) leads to:
½ChlB ¼
½Chltot  KB  ½Ptot 
½ChlB
nP
 
1 ½Ptot 
½ChlB
nP
 
 KB
ð5Þ
2.3.3. Förster's distance determination
According to Förster's theory of resonant energy transfer, the distance at
which half of energy emitted by the donor is absorbed by the acceptor, also
called the Förster's radius is given by:
R60 ¼ 8:8 1025  ðJ  j2  UD  n4Þ½cm ð6Þ
where κ is the dipole–dipole orientation factor, n the refractive index of the
medium, ΦD the donor fluorescence quantum yield in absence of acceptor. The
spectral overlap between the donor fluorescence and acceptor absorbance
spectrum, J, is given by:
J ¼
R
fDðkÞ  eAðkÞ  k4dkR
fDðkÞdk ð7Þ
The relationship between the energy transfer efficiency E and the donor–
acceptor distance r is:
E ¼ 1 Fl
F0
¼ R
6
0
R60 þ r6
  ð8Þ
where F∞ and F0 are the donor fluorescence intensities in presence and absence
of the acceptor, respectively.
In the case of LDL–Ce6 interaction, we used the values κ=0.66 for a
random orientation, ΦD=0.11 for the fluorescence quantum yield of tryptophan
in hydrophobic environment [25], and n=1.4 for the refractive index of the
aqueous buffer.3. Results
The fluorescence emission spectra of Ce6 in PBS, bound to
HSA, LDL and DOPC liposomes are presented in Fig. 2. HSA,
LDL or DOPC do not emit any fluorescence in the spectral
region between 500 and 750 nm. Ce6 concentration was
5×10−8 M. The excitation wavelength was set at 410 nm,
which allows the best discrimination between the various
environments. The concentrations of HSA and DOPC were high
enough to ensure association of all chlorin molecules (see
below). In the case of LDL, a minor non-bound fraction of Ce6
is responsible for the shoulder on the blue part of the spectrum.
The fluorescence emission maximum of Ce6 is observed at
660 nm in PBS. It is red-shifted to 668 nm upon binding to HSA
or DOPC liposomes and to 667 nm when associated to LDL.
Moreover, the fluorescence intensity increases. These spectral
changes are specific for the transfer of chlorin from an aqueous
to a hydrophobic environment [26]. They are sufficient to allow
the spectral decomposition required for the calculation of
binding constants as reported in Materials and methods.
Fig. 3 shows the chlorin fluorescence emission spectra in
PBS at pH 6.5, 7.4 and 8.0. An important decrease of the
fluorescence intensity and a small blue shift (3 nm) of the
emission band are observed when the pH is decreased.
3.1. Binding of Ce6 to DOPC liposomes
The interaction of Ce6 (5×10−8 M) with liposomes was
considered as a partition of the photosensitizer between the bulk
aqueous medium and the phospholipid bilayer. In the range of
concentrations used, the DOPC/Ce6 ratio was at least 500. It
was assumed that the binding of one Ce6 molecule does not
influence the fixation of others in our experimental conditions,
which means that the membrane presents an unlimited number
of “binding sites”. The fluorescence emission spectra of Ce6 at
different DOPC concentrations are shown in Fig. 4a. The
excitation wavelength was set at 408 nm, the fluorescence
excitation maximum of chlorin bound to liposomes. Fig. 4b
shows the changes of the fluorescence intensity at 670 nm, the
fluorescence emission maximum of Ce6 incorporated into the
Fig. 4. Evolution of fluorescence emission of Ce6 (5×10−8 M) upon
incorporation into DOPC liposomes at pH 7.4. The excitation wavelength was
set at 408 nm. (a) Fluorescence emission spectra. The DOPC concentration was
0, 0.17, 0.86, 1.73, 2.59, 4.75, and 6.48×10−4 M. The arrows indicate changes
upon liposome addition. (b) Evolution of the fluorescence intensity at 670 nm.
Experimental data are fitted according to Eq. (1) with an association constant
KDOPC of 5.9×10
3 M.
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constant value was determined by fitting the experimental data
to Eq. (1) (Fig. 4b). KDOPC values increase by one order of
magnitude in the pH range between 8.0 and 6.5 (Table 1).
3.2. Binding of Ce6 to HSA
Fluorescence emission spectra of Ce6 (5×10−9 M) solutions
containing increasing amounts of HSA were recorded with an
excitation wavelength set at 408 nm, the excitation maximum ofTable 1
Ce6 binding constants (M−1)
pH 6.5 7.4 8.0
KDOPC * (9.1±0.6)×10
3 (5.9±1.1)×103 (2.3±0.4)×103
KHSA (0.8±0.1)×10
8 (1.8±0.2)×108 (3.2±0.6)×108
KLDL (a) (12.2±1.7)×10
7 (a) (6.9±1.0)×107
(b) (5.7±1.0)×107
Values (a) and (b) for LDL were obtained from data shown in Fig. 5b and Fig. 7,
respectively.
* These values should be divided by 0.558 if only the outer hemileaflet of
liposomes is populated (see Discussion).Ce6 bound to HSA. Due to the high affinity of the chlorin
towards HSA, the equilibrium conditions necessary to deter-
mine an equilibrium constant are attained only at very low
protein concentrations. As a consequence, the Ce6 and HSA
concentrations were of the same order of magnitude in our
experimental conditions and it was not possible to assume that
free protein binding sites were in excess. Hence, the concentra-
tions of free and bound chlorin ([Chl]F and [Chl]B ) were
determined by spectral decomposition according to Eq. (2). The
total chlorin concentration, [Chl]tot, was a constant in our
experimental conditions. The free HSA concentration was
calculated by assuming nHSA equal to 1. Fitting data by using
Eq. (5) yielded the same affinity constant value, KHSA,
independently of the Ce6 concentration. Typical fits are
shown in Fig. 5a. Interestingly, binding of Ce6 to HSA was
pH-dependent with a binding constant decreasing at lower pH
(see Table 1).
3.3. Binding of Ce6 to LDL
3.3.1. Quenching of the LDL fluorescence by Ce6
Apoprotein B-100 contains 37 tryptophan and 151 tyrosine
residues that are responsible for the LDL fluorescence emission
at 333 nm. The overlap between the emission spectrum of LDL
and absorption spectrum of LDL bound Ce6 (Fig. 6a) indicates
that the resonant energy transfer from Trp–Tyr residues to Ce6Fig. 5. Binding of Ce6 to HSA (a) and LDL (b) at various pH. Data are fitted
according to Eq. (5). The association constants thus obtained are given in Table 1.
Fig. 6. (a) Fluorescence emission spectrum of LDL (excitation 280 nm, left) and
extinction coefficient spectrum of LDL-bound Ce6 (right). (b) Quenching of
LDL intrinsic fluorescence upon binding of chlorin e6. [LDL]: 6×10−8 M, Ce6/
LDL: 0.5–30 (excitation wavelength: 280 nm). The fluorescence intensity of
LDL without chlorin is normalized to 100%.
Fig. 7. Scatchard's plot of the Ce6 binding to LDL (5×10−8 M) following the
fluorescence emission of Ce6 (excitation wavelength 408 nm). The curve was
fitted by Eq. (11) with the following parameters: nPi: 10, KPi: 5×10
6 M−1, KL:
7×106 M−1. The global binding constant, KLDL, is 5.7×10
7 M−1.
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6.28×10−14 by using Eq. (7) (see Materials and methods). The
Försters's distance for the couple LDL–Ce6 calculated accord-
ing to Eq. (6) is about 3 nm.
The fluorescence emission of LDL solutions (5×10−8 M)
with the excitation wavelength set at 280 nm was measured in
the presence of increasing amounts of Ce6. The Ce6/LDL
concentration ratio ranged from 1 to 25. As shown in Fig. 6b,
quenching of the emission fluorescence at 333 nm plateaus
out at around 40% upon addition of Ce6. According to Eq.
(8), the mean distance between tryptophan residues and Ce6
would be about 3.2 nm. Hence, a significant part of Ce6
molecules binds to sites on the Apo B-100 component or in
close proximity. In addition, the intercept between the initial
slope of the quenching curve and the plateau indicates that
approximately ten chlorin molecules are bound per LDL
particle.
3.3.2. Ce6 fluorescence-Scatchard's plot
In order to get more information on a possible repartition of
Ce6 molecules between different LDL compartments, we
measured the changes of fluorescence emission of Ce6 upon
binding to LDL. This study was based on a model previously
developed by Bonneau et al. [27] that uses Scatchard's method.Binding of molecules to m different classes of binding sites can
be described by the general relationship [28]:
m ¼
Xm
i¼1
ni  Ki  ½ChlF
1þ Ki  ½ChlF
ð9Þ
where ν is the number of chlorin molecules bound per LDL,
[Chl]F is the free chlorin concentration at equilibrium, ni is the
number of sites for an homogeneous binding class and Ki the
corresponding intrinsic binding constant. In keeping with
former studies [27,29] and the above results, we considered
two binding classes. One involves nP sites with an intrinsic
association constant KPi in the proximity of the apoprotein, and
the other, binding to the lipid compartment. The latter process is
considered as a solubilization in the lipidic LDL moiety and can
be represented by a large number of sites nLi with a relatively
small intrinsic binding constant KLi. The overall binding
equation
m
½ChlF
¼ nP  KPi
1þ ½ChlF  KPi
þ nL  KLi
1þ ½ChlF  KLi
ð10Þ
can be simplified to
m
½ChlF
¼ nP  KPi
1þ ½ChlF  KPi
þ KL ð11Þ
with the assumption [Chl]F×KLi << 1 and KL = nLi×KLi.
The fluorescence emission spectra of solutions made with a
constant LDL concentration (5×10−8 M) and increasing Ce6
concentrations were recorded. The Ce6/LDL concentration ratio
ranged between 0.1 and 20. Free and bound Ce6 concentrations
were calculated for each spectrum according to the procedure
described above. The Scatchard's plot (see Fig. 7) shows a
curvature indicating that more than one class of sites is
involved. Fitting data to Eq. (11) confirms binding to a class
representing about 10 sites with a high intrinsic association
constant (KPi=5×10
6 M−1). Binding to the lipidic part with an
overall affinity constant KL=7×10
6 M−1 account for the
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binding modes is 5.7×107 M−1.
3.3.3. Binding of Ce6 to LDL and pH effect
The overall affinity constant of chlorin for LDL can also be
derived from Eq. (5) assuming that LDL possesses 10 binding
sites. Fluorescence emission spectra of Ce6 (1×10−8 M) were
recorded at different concentration of LDL. The overall
concentration of binding sites on LDL was not in excess
compared to the chlorin concentration in our experimental
conditions. Hence, data were treated as described above for
HSA to take free protein sites into account. The affinity of Ce6
for LDL is clearly pH dependent as shown in Fig. 5b. As high
pH may affect the LDL integrity, we limited our investigation to
pH 6.5 and 7.4. Results for LDL and HSA are compiled in Table
1. They clearly show an inverse dependence on pH of the
affinities of HSA and LDL for Ce6.
4. Discussion
4.1. Solution properties of chlorin e6
These properties were examined in details by Cunderlikova
et al. [7] as a function of pH. Upon pH decrease between 9 and
3.2, the chlorin fluorescence emission maximum was shifted
from 661 to 648 nm. Depending on whether peak position or
intensity of fluorescence was chosen by these authors to analyze
data, the reported titration curves displayed inflection points at
pH 5.9 or 6.5 [7]. Typical emission spectra in the pH range
considered in the present study are reported in Fig. 3. In keeping
with Cunderlikova's results a shoulder on the blue side of the
emission band is observed at the lowest pH. Different processes
may come into play to account for these changes. Firstly, the
three carboxylic chains of chlorin e6 could be neutralized
sequentially. For comparison, the pKa values for a dicarboxylic
porphyrin, deuteroporphyrin, were recently re-determined to be
6.6 and 5.3 [30]. In this compound, the fluorescence changes
resulting from the neutralization of the carboxylate chains were
interpreted more as a consequence of the favored formation of
non-fluorescent dimers than as a direct modification of the
spectroscopic properties of the macrocycle. This problem is not
excluded with chlorin e6 even if it was more water-soluble
owing to the presence of three carboxylic chains. It should be
emphasized that these chains differ by the number of carbon
atoms separating the carboxylic function from the macrocycle.
A direct effect of the carboxylic group closely attached to the
macrocycle on the spectroscopic properties might be supposed.
However, as excited states of tetrapyrrolic compounds involve
increased electronic distribution at the macrocycle periphery
[31], the neutralization of the carboxylate would most likely
lead to a spectral red shift. Alternatively, inner nitrogens can be
protonated. In related carboxylic porphyrins, the pKa value for
the first inner nitrogen being protonated was found to be around
5.3 for deuteroporphyrin [30] and 5.0 for hematoporphyrin [32].
The blue shift of chlorin e6 emission might be due to
protonation of the first inner nitrogen. It is conceivable that
the pK of this nitrogen could be somewhat increased ascompared to the value reported for porphyrins through the
possibility of zwitterion formation with the carboxylate adjacent
to the macrocycle. This does not exclude the neutralization of
the other chains in the same pH range leading to a decrease of
the overall charge and increase in lipophilicity. As a matter of
fact, as reported by Cunderlikova et al. [7], the octanol–water
partition coefficient of chlorin e6 increases with decreasing pH.
4.2. Chlorin e6 binding to membrane models
DOPC liposomes were chosen because of the low tempera-
ture of their main phase transition, − 18 °C [33], which permitted
us to observe, at 20 °C, the interactions of Ce6 with the lipid
bilayer in the liquid crystal phase. The red shift of the
fluorescence excitation and emission maxima is indicative of
incorporation of Ce6 into a hydrophobic environment [26]. In
keeping with results obtained with related carboxylic porphyr-
ins, it can be assumed that the chlorin macrocycle is buried into
the hydrophobic lipid core and the carboxylic chains are oriented
to the water interface [24,34]. The fluorescence characteristics of
the chlorin bound to the liposomes were independent of pH
indicating that in all cases, the free-base form, i.e. without inner
nitrogen protonated, is incorporated into the bilayer. Similar
behavior has been observed for porphyrins [35]. The binding
constant of Ce6 to DOPC liposomes increases by about one
order of magnitude when pH is lowered from 8.0 to 6.5.
Obviously, this increase cannot involve the protonation of
nitrogen, which would have the opposite effect. In this pH range,
the phosphocholine head of DOPC is not subject to acid–base
equilibria. Thus, only the neutralization of the carboxylic chains
of the chlorin can account for the observed effect. The resulting
increase of lipophilicity will result in an augmentation of its
affinity for the membrane. In the case of Ce6, the relatively short
lateral chains might restrict incorporation into the bilayer. In fact,
preliminary experiments suggest that the transfer of this
molecule through the bilayer is very slow (several hours). The
affinity constant measured corresponds most likely to incorpora-
tion only into the outer hemileaflet of the vesicles. Accordingly,
the affinity constant expressed as a function of accessible
phospholipids should be divided by 0.558, the ratio between the
lipids in the outer hemileaflet and the total number of lipids.
The value of the affinity constant of Ce6 to DOPC at pH 7.4
is significantly lower than that of deuteroporphyrin for egg
phosphatidylcholine vesicles [36]. Both molecules possess a
macrocycle of comparable lipophilicity, that of chlorin e6 with
vinyl and ethyl chains being even larger. The difference in
affinity appears to be related to the presence of three carboxylic
groups instead of two for the porphyrin and to the shorter
carboxylic chains in chlorin e6 impeding deep anchorage within
the bilayer.
4.3. Chlorin e6 binding to human serum albumin
Albumin, the most abundant protein in human plasma, has a
key role in the bioavailability and pharmacokinetics of drugs.
Data on the binding of tetrapyrroles to albumin and their
distribution among plasma proteins have been reviewed [19].
372 H. Mojzisova et al. / Biochimica et Biophysica Acta 1768 (2007) 366–374Most studies have focused on dicarboxylic porphyrins and
heme, the iron complex of protoporphyrin. A high affinity
binding site for porphyrin monomers has been identified
[37,38]. In a series of dicarboxylic porphyrin from the less
hydrophobic hematoporphyrin to the more hydrophobic
protoporphyrin, the affinity constants have been found to
range between about 1×106 and 3×108 M−1 [19]. No data
on pH effect were available except for hematoporphyrin, the
affinity of which is slightly higher in the pH range 6.8–7.5
(3.6×106 M−1) than at pH 8 (1.27×106 M−1) [39]. To our
knowledge, there are very few reports [40] on the affinity of
chlorins for albumin. At pH 7.4, chlorin e6 possesses an
affinity constant of 1.8×108 M−1, which is very similar to that
of the more hydrophobic and less water-soluble deuteropor-
phyrin, 1.9×108 M−1 [41], and protoporphyrin, 2.8×108 M−1
[42]. In fact, chlorin e6 shares with these molecules a common
assymetric structure. Their hydrophobic core bears polar
carboxylic chains on one side only. It can be hypothesized
that the high affinity site of dicarboxylic porphyrins or of
chlorin e6 is identical to that of heme. This site has been
characterized in subdomain IB of HSA. Heme is accommo-
dated in a hydrophobic pocket with its propionate groups
interacting with a triad of basic residues (lysine, arginine and
histidine) at the pocket entrance [38]. Chlorin e6 could be
accommodated in the same way, its three carboxylic groups
providing even better stabilization via salt-bridges with the
basic residues. The existence of at least four non-specific sites
accommodating porphyrins with much lower affinity was also
described [43], but these don’t seem to influence the
interactions in the concentration range studied. More likely,
only low affinity sites were probed in Kochubeev's paper [40].
Interestingly, the affinity of chlorin e6 decreases when the pH is
lowered from 8 to 6.5. This effect might be due to some
neutralization of the carboxylic groups reducing salt-bridge
stabilization. Besides, albumin was shown to undergo con-
formational changes in about the same pH range, which also
could modify affinity for the chlorin [44].
4.4. Chlorin e6 binding to low density lipoproteins
The over-expression of LDL-receptors by neoplastic cells
and the incorporation of photosensitizers associated to LDL
have been suggested to contribute to the specific accumulation
of photosensitizers in proliferative tissues [10–12]. This
hypothesis has been supported by experiments on cells and
tumor models. Among other examples, the cellular uptake and
photoactivity of porphyrins are increased through potentialisa-
tion of LDL catabolism by lovastatin [45]. Preferential
accumulation and retention of LDL-bound photosensitizers by
a fibrosarcoma tumor in mouse has been reported [46]. By
contrast, PDT resistant tumor cells have been shown to exhibit
low activity of LDL related receptors [47]. Furthermore,
experiments performed on an animal model with a very
hydrophobic photosensitizer have revealed both a particularly
high tumor uptake and an unprecedented high association with
low-density lipoproteins [48]. However, the relevance of the
low density lipoprotein receptor pathway for selective accumu-lation of the photosensitizer in tumors has been questioned
[49,50]. The known tumor localizing ability of various
photosensitizers is not correlated with their relative affinity
for LDL [18] indicating that other mechanisms may come into
play and/or other tumor compartments are also involved in
selectivity. In addition, the LDL lipid structures might serve as a
substrate for photoinduced peroxidation reactions and thus
could enhance the overall biological efficiency of the photo-
sensitizer [51]. Consequently, the affinity of photosensitizers for
LDL and the number of molecules bound per LDL particle are
important parameters. The distribution of the molecules
between the different LDL compartments is important as well.
This information has been derived from protein fluorescence
quenching and from change in chlorin fluorescence upon
binding to LDL.
In agreement with fluorescence quenching experiments, the
results described above led to the identification of about ten
sites close to the protein with a high intrinsic association
constant (KPi=5×10
6 M−1), which corresponds to an overall
affinity of 5×107 M−1. In keeping with previous studies [27,29]
and as derived in Results, non-specific binding to the lipid phase
of LDL with a constant KL=7×10
6 M−1 also takes place. It
may be noted that this constant is almost one order of magnitude
lower than the overall affinity for the ten sites mentioned above.
Taking into account the fact that one LDL particle contains
about 800 molecules of phospholipids, the ratio KL/800 leads to
a lipid binding constant of 8.75×103 M−1. It may be noted that
this value is very close to that measured for DOPC liposomes
after correction for accessible lipids (5.9×103 / 0.558 =
1×104 M−1). Whatever the LDL/Ce6 ratio, the shape and
position of the fluorescence emission spectra of the LDL-bound
chlorin were the same, indicating that the environment of
chlorin in the different LDL compartments is similar. Moreover,
these spectra are like those observed during the incorporation of
Ce6 into liposomes suggesting a hydrophobic environment in
all cases. Comparable results were obtained with deuteropor-
phyrin [27]. This suggests that the first class of sites associated
to tryptophan fluorescence quenching more likely involves the
lipid–protein interface.
The global affinity constant at pH 7.4 calculated by the
Scatchard's method, (KLDL=5.7×10
7 M−1) or derived from
Fig. 5 (6.9×107 M−1) are in good agreement within experi-
mental uncertainty. The global affinity constant of Ce6 for LDL
is mainly governed by the fixation at “protein” sites and the
partition into lipid compartments is rather a minority process.
This affinity constant is about one order of magnitude lower
than that determined for deuteroporphyrin [27]. As discussed
above, the same difference was found in the case of binding to
liposomes. This supports again the view that the “protein” sites
more likely correspond to hydrophobic regions at the boundary
between apoprotein B100 and the LDL lipid phase. The affinity
of Ce6 for LDL is very close to that of aluminum
phthalocyanine sulfonated on two adjacent isoindole units,
AlPcS2a [52]. The decreased LDL affinity of AlPcS2a might be
due to the permanent negative charge of the sulfonate groups,
the pK of which is far below the physiological pH. In the case of
Ce6 this might be due to the extra polar carboxylic group and/or
373H. Mojzisova et al. / Biochimica et Biophysica Acta 1768 (2007) 366–374to the shortest lateral alkyl chains as compared to deuteropor-
phyrin. In keeping with the role of the charge of macrocycle side
chains, we observed an increase of the global association
constant by a factor of about 2 when the pH was decreased from
7.4 to 6.5. It may also be noted that each LDL particle binds
about 10 Ce6 molecules, which is 5 times less than the value
reported for more lipophilic photosensitizers [11,27].
4.5. The pH-dependent distribution of Chlorin e6 among
plasma proteins
As outlined above, the relative distribution of photosensiti-
zers between plasma components is an important determinant of
their efficiency. Ultracentrifugation or gel exclusion chromato-
graphy experiments can give an overall picture of the
distribution pattern. However, these two methods and/or
differences in experimental protocols were found to yield
conflicting results as reviewed by Kongshaug [19]. In the
present work, we choose to derive quantitative binding data on
isolated plasma proteins and membrane models. Albumin
appears to be the major carrier in agreement with former data
obtained by ultracentrifugation [21]. However, a striking feature
of the data reported in Table 1 is the inverse dependence on pH
of the affinity constants of Ce6 for HSA and LDL. The ratio
KLDL/KHSA is multiplied by 4.6 when pH is decreased from 7.4
to 6.5. A parallel effect is expected for the partition of Ce6
between HSA and membranes, the ratio KDOPC/KHSA being
multiplied by 3.5 for the same pH change. Although the
concentrations of free chlorin or LDL-bound chlorin are
expected to be fairly low, this pH effect might be significant.
Indeed, different studies have shown that the pH of the
interstitial fluid in tumors is lower than that in the normal tissues
[4,53,54]. This peculiarity reflects the excretion of lactic acid by
tumor cells that present high rate of anaerobic glucose
metabolism. The potential use of acid pH in tumors for
therapeutic exploitation has been outlined [5,55], a suggestion
also valid for carboxylic photosensitizers [56]. A comprehen-
sive review of microelectrode measurements in human and
animal tumors illustrating this effect has been published [53].
Although acidification is dependent on the size and histology of
the tumor, the distributions of pH values obtained for
subcutaneous normal tissues and tumors in human were found
to have median values of about 7.5 and 7.0, respectively [53]. In
a series of 14 human tumors of various histologies, Thistle-
thwaite [54] has reported a mean pH value of about 6.81. There
was quite a large heterogeneity of pH within tumor and values
as low as 5.55 were measured [54].
In the present study, we have selected a wide range of pH
values in order to clearly illustrate, in vitro, the feasibility of a
pH-dependent redistribution of chlorin e6 in the tumor stroma.
We have quantified the change of chlorin e6 affinity towards
HSA, LDL and lipid membranes as a function of pH. Although
albumin is the major carrier for chlorin e6, some decrease of the
stability of the Ce6–HSA complex and concomitant increase of
binding to LDL and membranes upon small pH decrease could
favor preferential uptake of such photosensitizers by tumors.
These data illustrate the interest of quantitative information onthe affinity of photosensitizers for their various carriers with
emphasize on specific tumor properties, which could help in the
rational design of more selective photosensitizers.
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